ACHL
Achilles Therapeutics
ACHL
ACHL
Delisted
ACHL was delisted on the 20th of March, 2025.
18 hedge funds and large institutions have $17.9M invested in Achilles Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$57.4K | |
| 2 | +$19.2K | |
| 3 | +$5.56K | |
| 4 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$3.09K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$66 |
Top Sellers
| 1 | -$94.5K | |
| 2 | -$20.7K | |
| 3 | -$20.1K | |
| 4 |
VF
Virtu Financial
New York
|
-$16K |
| 5 |
Renaissance Technologies
New York
|
-$11.1K |